Evidence map›Paper›PMID 41835499›Full record

ArticleACS omega2026

Tryptophanase Mining and Characterization toward the Biological Production of Indole Derivatives.

Ruben M de Boer, David Harding-Larsen, Stanislav Mazurenko, Ditte Hededam Welner

Abstract read
In one paragraph

Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ruben M de BoerThe Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kongens Lyngby 2800, Denmark.ORCID https://orcid.org/0000-0002-2239-7286
David Harding-LarsenThe Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kongens Lyngby 2800, Denmark.ORCID https://orcid.org/0009-0001-7800-2669
Stanislav MazurenkoLoschmidt Laboratories, Department of Experimental Biology and RECETOX, Faculty of Science, Masaryk University, Brno 625 00, Czech Republic.ORCID https://orcid.org/0000-0003-3659-4819
Ditte Hededam WelnerThe Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kongens Lyngby 2800, Denmark.ORCID https://orcid.org/0000-0001-9297-4133

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tryptophan is an essential amino acid, and its fermentation-based synthesis is well-described with double-digit titers. Therefore, tryptophanase may serve as the gateway enzyme toward indole-derived biobased molecules. They are widespread PLP-dependent enzymes with a conserved active site. Even though their function and structure are well described, the number of characterized tryptophanases is rather low. Here, we characterized a panel of tryptophanases mined from public databases, aimed to explore their industrial amenability. We used the machine learning method variational autoencoding to visualize the tryptophanase sequence space and ensure that the natural sequence diversity is covered in our panel. After initial experiments, the gathered information was used to identify 2 additional regions of interest in the visualized latent space. The solubly expressed enzymes (18 of 21) were biochemically characterized for optimal reaction conditions and kinetic parameters. The characterized panel encompassed a diverse set of tryptophanases with distinct optimal conditions, facilitating the selection of an appropriate candidate. The most suitable tryptophanase, PreTIL, was used in an enzymatic cascade toward biobased indigo synthesis. Optimal cosubstrate and enzyme concentrations were determined by Design of Experiments, resulting in 3.0 ± 0.8 mM indigo formation in situ. Though this titer is comparable to reports on indigo synthesis through fermentation, a fundamental phenomenon appears to halt biocatalytic indigo synthesis.

Identifiers

PMID41835499
PMCPMC12980246

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.